NURS 5430 Test 2 – Questions With Expert
Solutions
Save Groups
Practice questions for this set
Learn 1 /7 Study using Learn
Hemoglobin or Hematocrit more than 2 standard deviations below mean for age
and sex specific reference population
Choose an answer
1 Clinical Manifestations COVID-19 2 Threshold for diagnosis of anemia
3 Enteroviruses 4 COVID-19 Management
Don't know?
Terms in this set (118)
,Clinical Manifestations COVID-19 Typically Asymptomatic, or with mild/moderate
symtoms
Fever, cough, SOB
Myalgia
Rhinorrhea
Sore Throat
Headache
Nausea/Vomiting
Diarrhea
Abd Pain
Loss of smell or taste (10%)
Labs for COVID-19 CBC (typically normal)
C-reactive Protein (1/3 showed elevation)
CK (elevated in 15%)
Serum Aminotransferases (12% elevated)
Severe COVID-19 Risk Factors Asthma
Medical Complexity
Neurological Conditions
Metabolic Conditions
Immunosuppression
Obesity
Diabetes
Sickle Cell
Multisystem Inflammatory Syndrome Rare but Serious Condition
in Children (MIS-C) Presentation similar to Kawasaki disease and TSS
Symptoms:
Persistent Fever
Hypotension (Hypovolemic)
GI Symptoms
Rash
Myocarditis ***Very concerning
Labs consistent with increased inflammation
* Will need ICU admission*
, COVID-19 Management *First have to determine severity*
Treatments based on presentation
Supportive care first line
Respiratory support:
- Supplementary oxygenation or ventilation
*** Remember Children respiratory status can
change abruptly, usually 7 days after symptoms
present**
Fluid and Electrolytes:
- Avoiding dehydration/ hypovolemia
COVID-19 Home Management Prevention of transmission to others
- Isolation, mask, hand hygiene
Monitor for clinical deterioration
Symptom management
Avoid unproven interventions
Bamlanivamb-Etesvimab or Only given for hospitalized patients
Casirivmab-Imdevimab Administration 12-17 y/o w/ following risk factors for drug
Guidelines administration:
BMI >85th percentile
CKD
DM
Immunosuppression
Congenital or acquired heart disease
Neurodevelopmental disorders
Chronic Respiratory Disease
Febrile Infant Management (<28 days) Under 28 Days:
Urinalysis/ Urine culture
CBC w/ Diff
CRP
Procalcitonin
Blood Culture
Spinal Tap
Solutions
Save Groups
Practice questions for this set
Learn 1 /7 Study using Learn
Hemoglobin or Hematocrit more than 2 standard deviations below mean for age
and sex specific reference population
Choose an answer
1 Clinical Manifestations COVID-19 2 Threshold for diagnosis of anemia
3 Enteroviruses 4 COVID-19 Management
Don't know?
Terms in this set (118)
,Clinical Manifestations COVID-19 Typically Asymptomatic, or with mild/moderate
symtoms
Fever, cough, SOB
Myalgia
Rhinorrhea
Sore Throat
Headache
Nausea/Vomiting
Diarrhea
Abd Pain
Loss of smell or taste (10%)
Labs for COVID-19 CBC (typically normal)
C-reactive Protein (1/3 showed elevation)
CK (elevated in 15%)
Serum Aminotransferases (12% elevated)
Severe COVID-19 Risk Factors Asthma
Medical Complexity
Neurological Conditions
Metabolic Conditions
Immunosuppression
Obesity
Diabetes
Sickle Cell
Multisystem Inflammatory Syndrome Rare but Serious Condition
in Children (MIS-C) Presentation similar to Kawasaki disease and TSS
Symptoms:
Persistent Fever
Hypotension (Hypovolemic)
GI Symptoms
Rash
Myocarditis ***Very concerning
Labs consistent with increased inflammation
* Will need ICU admission*
, COVID-19 Management *First have to determine severity*
Treatments based on presentation
Supportive care first line
Respiratory support:
- Supplementary oxygenation or ventilation
*** Remember Children respiratory status can
change abruptly, usually 7 days after symptoms
present**
Fluid and Electrolytes:
- Avoiding dehydration/ hypovolemia
COVID-19 Home Management Prevention of transmission to others
- Isolation, mask, hand hygiene
Monitor for clinical deterioration
Symptom management
Avoid unproven interventions
Bamlanivamb-Etesvimab or Only given for hospitalized patients
Casirivmab-Imdevimab Administration 12-17 y/o w/ following risk factors for drug
Guidelines administration:
BMI >85th percentile
CKD
DM
Immunosuppression
Congenital or acquired heart disease
Neurodevelopmental disorders
Chronic Respiratory Disease
Febrile Infant Management (<28 days) Under 28 Days:
Urinalysis/ Urine culture
CBC w/ Diff
CRP
Procalcitonin
Blood Culture
Spinal Tap
